APRIL M CRUICKSHANK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family COLORADO SPRINGS, CO NPI 1316337124

General Payments — all program years on this page

$665.53

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $437.34 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $353.3420
Education $84.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $228.196
2024 $437.3421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078423083 Janssen Biotech, Inc. $84.00 07/11/2024 Education Undisputed 01/23/2026 View at CMS
1133710409 Gilead Sciences, Inc. $10.43 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710411 Gilead Sciences, Inc. $8.52 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710413 Gilead Sciences, Inc. $8.67 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710415 Gilead Sciences, Inc. $33.22 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710417 Gilead Sciences, Inc. $20.05 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710419 Gilead Sciences, Inc. $25.76 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710421 Gilead Sciences, Inc. $15.89 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710423 Gilead Sciences, Inc. $10.52 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710425 Gilead Sciences, Inc. $21.27 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710427 Gilead Sciences, Inc. $26.76 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710429 Gilead Sciences, Inc. $9.72 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710431 Gilead Sciences, Inc. $9.36 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710433 Gilead Sciences, Inc. $34.58 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710435 Gilead Sciences, Inc. $7.54 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710437 Gilead Sciences, Inc. $23.65 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710439 Gilead Sciences, Inc. $6.58 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710441 Gilead Sciences, Inc. $21.97 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147742424 QOL Medical, LLC $23.35 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147742426 QOL Medical, LLC $16.46 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153608992 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.04 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.